Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV001170327 | SCV001332898 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-01-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001170327 | SCV001344597 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001433600 | SCV001636391 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-08-05 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004803437 | SCV005424946 | likely benign | Marfan syndrome | 2024-05-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001170327 | SCV005585839 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-11-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |